Utah Code § 26B-7-121

Current through the 2024 Fourth Special Session

Section 26B-7-121 - Sickle cell disease

In collaboration with the Medicaid program as defined in Section 26B-3-101, the Drug Utilization Review Board created in Section 26B-3-302, the Health Data Committee created in Section 26B-1-413, the Office of Health Disparities Reduction created in Section 26B-7-114, and others within the department, the Division of Population Health created in Section 26B-1-204 shall:

(1) review and develop recommendations for improving the surveillance, screening, diagnosis, and treatment of sickle cell disease among residents of the state; and

(2) report the recommendations to the Health and Human Services Interim Committee before July 1, 2024.

Utah Code § 26B-7-121

Added by Chapter 465, 2023 General Session ,§ 1, eff. 5/3/2023, technically renumbered to avoid duplication.